clinical management plans workshop - lead lecture.ppt

8/14/2019 Clinical Management Plans Workshop - Lead Lecture.ppt

1/13

When to use supplementary prescribing

and

How to write a clinical management plan

Kimberley Tordoff


2/13

Introduction

On completion of this course you will gain

a qualification of being an IP & SP

Therefore you must demonstrate the

ability to complete a clinical management

plan required for supplementary

prescribing

Errors on your clinical management plan

(CMP) may lead you to fail your portfolio


3/13

Uses of CMP

Long term conditions

Useful if working in a new area

Useful for prescribing Controlled Drugs(CDs)

Widely used before the whole BNF

opened


4/13

CMPs

Blank templates on Department of Healthwebsite

You may use your own version as long asALL the legally required information is there

Choose the one appropriate to your practice(do you have access to the notes or not?)

Only put one condition to be treated or one

symptom For CMPs to work they need to be quick andsimple (NPC 2003)


5/13

CMPs

You are the SP and the doctor is the IP

If more than one SP all must be listed by name and

all must sign in the relevant section to enable more

than one SP in a team to use the plan. Use the patient details & address in your module

guide

Fill in the patient details including an NHS number

(false)

Condition to be treated

Aim of the treatment; be specific e.g. BP between x

& x or Hba1c @ x, peak flow over x.


6/13

CMPs

Preparation can be the name of 1 drug if it is that

specific, but a plan works better if it is over a

range of drugs or the whole class of drugs

Include the section of the BNF e.g. Section3.2.1of BNF vol 61 2011 (Joint Formulary

Committee, 2011).

If you are experienced in this area then you

would want a range of drugs

Doserange of dose to prescribe for a specific

drug or as per section 3.2.1. of BNF vol 61 2011

(Joint Formulary Committee, 2011).


7/13

CMPs

Reasons for referral back to IP

Be specific and not vague-if you put sideeffects then you would have to refer back forevery single slight problem

Think about this in reality

BP above x on x occasions despite maximumdose

Cough on ace may not be needing to do backto see IP if you have given yourself a wideenough section of BNF so you can try analternative


8/13

Guidelines & Protocols

Must include BNF with volume number

and date

Guidelines referenced properly

These can be local as long as they are

recognised and robust


9/13

Review & Record

Frequency of review is a heading and

must be completed

Put a time frame for IP & SP

IP must be at least yearly

SP must be more frequent than IP

Whatever the shared record is thendocument it e.g. hospital notes, EMIS.


10/13

Adverse Drug Reactions (ADRs)

Inform IP

Document in patients notes

Inform MHRA via yellow card system

Signatures are needed NOT typed names

Dated

Patients signature is not required but document innotes that they have given informed consent

When you write out your prescription thepharmacist you must know that you areprescribing within a CMP so write SP after yourname


11/13

Conclusion

This is a fictitious CMP so don't worry that

you are signing something illegally

Get this done soon whilst it is fresh in your

mind


12/13

References

Joint Formulary Committee British NationalFormulary(61) Ed. London: British MedicalAssociation and Royal PharmaceuticalSociety (2011)

National Prescribing Centre (2003) (NPC)Supplementary Prescribing A resource tohelp healthcare professionals to understandthe framework and opportunities

http://www.npc.nhs.uk/resources/healthcare_resource.pdf
http://www.npc.nhs.uk/resources/healthcare_resource.pdfhttp://www.npc.nhs.uk/resources/healthcare_resource.pdfhttp://www.npc.nhs.uk/resources/healthcare_resource.pdfhttp://www.npc.nhs.uk/resources/healthcare_resource.pdf


13/13

This work was produced as part of the TIGER project and funded by JISC and

the HEA in 2011. For further information see:

http://www.northampton.ac.uk/tiger.

This work by TIGER Project is licensed under a Creative Commons

Attribution-NonCommercial-ShareAlike 3.0 Unported License. Based on a

work at tiger.library.dmu.ac.uk.

The TIGER project has sought to ensure content of the materials comply with

a CC BY NC SA licence. Some material links to third party sites and may use

a different licence, please check before using. The TIGER project nor any of

its partners endorse these sites and cannot be held responsible for their

content. Any logos or trademarks in the resource are exclusive property of

their owners and their appearance is not an endorsement by the TIGER

project.
http://www.northampton.ac.uk/tigerhttp://tiger.library.dmu.ac.uk/http://tiger.library.dmu.ac.uk/http://www.northampton.ac.uk/tiger

clinical management plans workshop - lead lecture.ppt

Documents